Literature DB >> 19028573

Absorption kinetics of insulin after subcutaneous administration.

Tue Søeborg1, Christian Hove Rasmussen, Erik Mosekilde, Morten Colding-Jørgensen.   

Abstract

Many diabetic patients depend on regular and well-controlled administration of insulin to avoid unacceptable excursions in plasma glucose. A complicating factor is that the absorption of insulin shows a considerable variability, both between patients, and from administration to administration for the same patient. To understand the mechanisms that influence this variability we present a quantitative description of the absorption kinetics for both soluble insulin and insulin crystals. The concentration dependent distribution of insulin between different oligomers is first analysed and described. Next, the disappearance of soluble and crystalline insulin from subcutis is described and explained as a function of the administered dose, the insulin concentration and crystal specific parameters, but without diffusion. The effect of diffusion is then included, and the appearance of insulin in plasma following subcutaneous administration is simulated and discussed. Our results not only explain the observed variability, but they also explain how dose size, insulin concentration, insulin crystals etc. influence the absorption kinetics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028573     DOI: 10.1016/j.ejps.2008.10.018

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  17 in total

1.  Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs.

Authors:  Alfred J Harvey; Scott A Kaestner; Diane E Sutter; Noel G Harvey; John A Mikszta; Ronald J Pettis
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

2.  Accelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidase.

Authors:  Douglas B Muchmore; Daniel E Vaughn
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

Review 3.  New Basal Insulins: a Clinical Perspective of Their Use in the Treatment of Type 2 Diabetes and Novel Treatment Options Beyond Basal Insulin.

Authors:  Patrick F Frias; Juan Pablo Frias
Journal:  Curr Diab Rep       Date:  2017-08-18       Impact factor: 4.810

Review 4.  Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations.

Authors:  Douglas B Muchmore; Daniel E Vaughn
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

5.  Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site.

Authors:  Anjul Khadria; Chad D Paavola; Konstantin Maslov; Francisco A Valenzuela; Andrea E Sperry; Amy L Cox; Rui Cao; Junhui Shi; Patricia L Brown-Augsburger; Emmanuel Lozano; Ross L Blankenship; Ranajoy Majumdar; Scott A Bradley; John M Beals; Sunday S Oladipupo; Lihong V Wang
Journal:  Mol Metab       Date:  2022-06-04       Impact factor: 8.568

6.  Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes.

Authors:  F Smeeton; F Shojaee Moradie; R H Jones; L Westergaard; H Haahr; A M Umpleby; D L Russell-Jones
Journal:  Diabetologia       Date:  2009-08-26       Impact factor: 10.122

7.  Ultra-rapid absorption of recombinant human insulin induced by zinc chelation and surface charge masking.

Authors:  Roderike Pohl; Robert Hauser; Ming Li; Errol De Souza; Robert Feldstein; Richard Seibert; Koray Ozhan; Nandini Kashyap; Solomon Steiner
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

8.  Is dynamic autocrine insulin signaling possible? A mathematical model predicts picomolar concentrations of extracellular monomeric insulin within human pancreatic islets.

Authors:  Minghu Wang; Jiaxu Li; Gareth E Lim; James D Johnson
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

Review 9.  A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations.

Authors:  M Evans; P M Schumm-Draeger; J Vora; A B King
Journal:  Diabetes Obes Metab       Date:  2011-08       Impact factor: 6.577

10.  A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets.

Authors:  Peter Buchwald
Journal:  Theor Biol Med Model       Date:  2011-06-21       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.